Literature DB >> 21210474

A model for a new pyramid of prenatal care based on the 11 to 13 weeks' assessment.

Kypros H Nicolaides.   

Abstract

Mesh：

Year:  2011        PMID： 21210474     DOI： 10.1002/pd.2685

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN： 0197-3851            Impact factor:   3.050


× No keyword cloud information.
  19 in total

Review 1.  Prenatal diagnosis of spina bifida: from intracranial translucency to intrauterine surgery.

Authors:  Waldo Sepulveda; Amy E Wong; Francisco Sepulveda; Juan L Alcalde; Juan C Devoto; Felipe Otayza
Journal:  Childs Nerv Syst       Date:  2017-06-07       Impact factor: 1.475

2.  First-Trimester Detection of Surface Abnormalities: A Comparison of 2- and 3-Dimensional Ultrasound and 3-Dimensional Virtual Reality Ultrasound.

Authors:  Leonie Baken; Melek Rousian; Anton H J Koning; Gouke J Bonsel; Alex J Eggink; Jérôme M J Cornette; Ernst M Schoonderwaldt; Margreet Husen-Ebbinge; Katinka K Teunissen; Peter J van der Spek; Eric A P Steegers; Niek Exalto
Journal:  Reprod Sci       Date:  2014-01-18       Impact factor: 3.060

3.  IUGR Is Associated With Marked Hyperphosphorylation of Decidual and Maternal Plasma IGFBP-1.

Authors:  Madhulika B Gupta; Majida Abu Shehab; Karen Nygard; Kyle Biggar; Sahil S Singal; Nanette Santoro; Theresa L Powell; Thomas Jansson
Journal:  J Clin Endocrinol Metab       Date:  2019-02-01       Impact factor: 5.958

4.  Screening Performance and Costs of Different Strategies in Prenatal Screening for Trisomy 21.

Authors:  K O Kagan; M Schmid; M Hoopmann; P Wagner; H Abele
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-03       Impact factor: 2.915

Review 5.  Inflammatory and Other Biomarkers: Role in Pathophysiology and Prediction of Gestational Diabetes Mellitus.

Authors:  Sally K Abell; Barbora De Courten; Jacqueline A Boyle; Helena J Teede
Journal:  Int J Mol Sci       Date:  2015-06-11       Impact factor: 5.923

6.  Evaluation of non-invasive prenatal testing (NIPT) for aneuploidy in an NHS setting: a reliable accurate prenatal non-invasive diagnosis (RAPID) protocol.

Authors:  Melissa Hill; David Wright; Rebecca Daley; Celine Lewis; Fiona McKay; Sarah Mason; Nicholas Lench; Abigail Howarth; Christopher Boustred; Kitty Lo; Vincent Plagnol; Kevin Spencer; Jane Fisher; Mark Kroese; Stephen Morris; Lyn S Chitty
Journal:  BMC Pregnancy Childbirth       Date:  2014-07-16       Impact factor: 3.007

Review 7.  Biomarker development for presymptomatic molecular diagnosis of preeclampsia: feasible, useful or even unnecessary?

Authors:  Sinuhe Hahn; Olav Lapaire; Nandor Gabor Than
Journal:  Expert Rev Mol Diagn       Date:  2015-03-16       Impact factor: 5.225

8.  Comparative Study of Endothelial Function and Uterine Artery Doppler Velocimetry between Pregnant Women with or without Preeclampsia Development.

Authors:  Augusto Henriques Fulgêncio Brandão; Ludmila Maria Guimarães Pereira; Alessandra Cristina de Oliveira Gonçalves; Zilma Silveira Nogueira Reis; Henrique Vítor Leite; Antônio Carlos Vieira Cabral
Journal:  J Pregnancy       Date:  2012-07-19

Review 9.  Prenatal Screening Using Maternal Markers.

Authors:  Howard Cuckle
Journal:  J Clin Med       Date:  2014-05-09       Impact factor: 4.241

10.  Clinical utility and cost of non-invasive prenatal testing with cfDNA analysis in high-risk women based on a US population.

Authors:  Ken Song; Thomas J Musci; Aaron B Caughey
Journal:  J Matern Fetal Neonatal Med       Date:  2013-03-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.